A Phase III, 8-week, Multicenter, Randomized, Double-blind Study to Compare the Efficacy and Safety of Amlodipine 5mg+Losartan 50mg Versus Amlodipine 10mg in Patients With Essential Hypertension Not Controlled on Amlodipine Monotherapy.
Phase of Trial: Phase III
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Amlodipine/losartan (Primary) ; Amlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Hanmi Pharmaceutical
- 17 Oct 2016 Last checked against ClinicalTrials.gov record.
- 30 Nov 2011 Primary endpoint 'Diastolic-blood-pressure' has been met.
- 23 Jul 2009 New trial record
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History